⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX LEGAL ALERT: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action due to Drug Trial Results -- Investors Notified to Contact BFA Law by December 15
globenewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Pomerantz LLP Issues Reminder to MoonLake Immunotherapeutics Investors – MLTX
accessnewswire.com
MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX
prnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
MLTX
Investor Alert: Deadline Approaching to Join MoonLake Immunotherapeutics (MLTX) Class Action – Contact Levi & Korsinsky
accessnewswire.com
MLTX
Faruqi & Faruqi Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX
prnewswire.com
MLTX
MLTX LAWSUIT: BFA Law Reminds MoonLake Immunotherapeutics Investors the Company has been Sued for Securities Fraud and to Contact BFA Law by December 15 Deadline
newsfilecorp.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
MLTX DEADLINE: ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX
globenewswire.com
MLTX